Clinical Trial Update: Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing prasugrel with a double-dose clopidogrel regimen for clopidogrel low-responsiveness after PCI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: Lene Holmvang | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED